ClinConnect ClinConnect Logo
Search / Trial NCT06879613

Comparing Breastmilk, Massage, and no Intervention for Pain Management During Vaccination of Term Infants

Launched by UNIVERSITY OF BAMENDA · Mar 13, 2025

Trial Information

Current as of April 29, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Neonates born at or after 37 completed weeks of gestation.
  • Neonates scheduled to receive the DTC-HepB-Hib-1 immunization.
  • Time from last feeding should be greater than or equal to 30 minutes.
  • Exclusion Criteria:
  • Term neonates with major congenital abnormalities like limb contractures, limb deformities.
  • Term neonates with any neurological conditions like hydrocephalus, cerebral palsy or birth asphyxia.
  • Infants with acute illness.
  • Infants randomized for no intervention but mothers breastfeed before pain evaluation to calm the babies from crying.

About University Of Bamenda

The University of Bamenda is a distinguished academic institution committed to advancing health research and education in Cameroon and beyond. As a clinical trial sponsor, the university leverages its expertise in various fields, including public health, medicine, and social sciences, to facilitate innovative research that addresses local and global health challenges. With a focus on ethical practices and community engagement, the University of Bamenda fosters collaboration among researchers, healthcare professionals, and stakeholders to enhance the quality of clinical trials and contribute to evidence-based solutions for improved health outcomes.

Locations

Bamenda, Northwest Region, Cameroon

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported